The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Sales reflect continued strong growth in oncology and vaccines
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
Subscribe To Our Newsletter & Stay Updated
